M&A TRANSACTION · 2022
Surgical Innovation Associates, Inc. (DuraSorb) acquired by Integra Lifesciences Holdings Corp.
$113.5M· 22.70x revenue
Target
Surgical Innovation Associates, Inc. (DuraSorb)
Acquirer
Integra Lifesciences Holdings Corp.
Strategic buyer
Disclosed financials at time of acquisition
Revenue
$5.0M
EBITDA
—
Deal Value
$113.5M
EV/EBITDA
—
Context
This $113.5M acquisition of Surgical Innovation Associates, Inc. (DuraSorb) by Integra Lifesciences Holdings Corp. sits in the medical devices sub-vertical. Integra Lifesciences Holdings Corp. is acquiring as a strategic buyer; see how strategic acquirers typically price medical devices businesses on our Medical Devices strategic buyer-pool page.
Source
Data sourced from SEC filings and press releases. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology
Value your own medical devices
Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.
Compare your business to the Surgical Innovation Associates, Inc. (DuraSorb) acquisition.